| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients
|
Zhang, Hangyu
|
|
2019
|
12 |
3 |
p. 426-431
|
artikel
|
| 2 |
Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
|
Kosgodage, Uchini S.
|
|
2019
|
12 |
3 |
p. 513-522
|
artikel
|
| 3 |
Claudin 1 Is Highly Upregulated by PKC in MCF7 Human Breast Cancer Cells and Correlates Positively with PKCε in Patient Biopsies
|
Blanchard, Anne A.
|
|
2019
|
12 |
3 |
p. 561-575
|
artikel
|
| 4 |
Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
|
Shahi Thakuri, Pradip
|
|
2019
|
12 |
3 |
p. 404-416
|
artikel
|
| 5 |
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis
|
Tiedemann, Kerstin
|
|
2019
|
12 |
3 |
p. 462-474
|
artikel
|
| 6 |
In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity
|
Seltzsam, Steve
|
|
2019
|
12 |
3 |
p. 417-425
|
artikel
|
| 7 |
Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients
|
Catacchio, Ivana
|
|
2019
|
12 |
3 |
p. 585-595
|
artikel
|
| 8 |
Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases
|
Donner, David B.
|
|
2019
|
12 |
3 |
p. 550-560
|
artikel
|
| 9 |
Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting
|
Ma, Cheng-Jen
|
|
2019
|
12 |
3 |
p. 502-512
|
artikel
|
| 10 |
Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
|
Zhang, Wentao
|
|
2019
|
12 |
3 |
p. 485-492
|
artikel
|
| 11 |
Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment
|
Cai, Qingqing
|
|
2019
|
12 |
3 |
p. 523-538
|
artikel
|
| 12 |
Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer
|
Angajala, Anusha
|
|
2019
|
12 |
3 |
p. 493-501
|
artikel
|
| 13 |
Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds
|
Gorshkov, Kirill
|
|
2019
|
12 |
3 |
p. 441-452
|
artikel
|
| 14 |
Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers
|
Nilsen, Anja
|
|
2019
|
12 |
3 |
p. 576-584
|
artikel
|
| 15 |
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
|
Leeman, Hayley
|
|
2019
|
12 |
3 |
p. 397-403
|
artikel
|
| 16 |
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma
|
Tamma, Roberto
|
|
2019
|
12 |
3 |
p. 545-549
|
artikel
|
| 17 |
The Role of TGF-β and Its Receptors in Gastrointestinal Cancers
|
Luo, Jingwen
|
|
2019
|
12 |
3 |
p. 475-484
|
artikel
|
| 18 |
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
|
Yang, Jie
|
|
2019
|
12 |
3 |
p. 453-461
|
artikel
|
| 19 |
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC
|
Gammelgaard, Kristine Raaby
|
|
2019
|
12 |
3 |
p. 432-440
|
artikel
|
| 20 |
Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer
|
Shimura, Takaya
|
|
2019
|
12 |
3 |
p. 539-544
|
artikel
|
Tijdschrift beschrijving